Glenmark Therapeutics Inc., USA (Glenmark) has launched Olopatadine Hydrochloride Ophthalmic Solution USP, 0.1% (OTC); compare to the active ingredient in Pataday2 Twice Daily Relief.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
